PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Bridge Biotherapeutics Reports P-IIa Clinical Trial Results of BBT-401 for the Treatment of Ulcerative Colitis

Bridge Biotherapeutics Reports P-IIa Clinical Trial Results of BBT-401 for the Treatment of Ulcerative Colitis

February 21, 2023

Top 20 Radiopharma Companies Based on Market Cap

Top 20 Radiopharma Companies Based on Market Cap

February 21, 2023

Junshi Biosciences Reports P-III (TORCHLIGHT Study) Results of Toripalimab for Advanced Triple-Negative Breast Cancer

Junshi Biosciences Reports P-III (TORCHLIGHT Study) Results of Toripalimab for Advanced Triple-Negative Breast Cancer

February 21, 2023

Travere Therapeutics’ Filspari (sparsentan) Receives the US FDA’s Accelerated Approval for the Reduction of Proteinuria in IgA Nephropathy

Travere Therapeutics’ Filspari (sparsentan) Receives the US FDA’s Accelerated Approval for the Reduction of Proteinuria in IgA Nep...

February 21, 2023

Apellis’ Syfovre Receives the US FDA’s Approval as the First Treatment for Geographic Atrophy

Apellis’ Syfovre Receives the US FDA’s Approval as the First Treatment for Geographic Atrophy

February 21, 2023

BMS Reports P-III Trial (CheckMate-274) Results of Opdivo (nivolumab) for High-Risk Muscle-Invasive Urothelial Carcinoma

BMS Reports P-III Trial (CheckMate-274) Results of Opdivo (nivolumab) for High-Risk Muscle-Invasive Urothelial Carcinoma

February 21, 2023

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us